Introducing our people
Challenges facing the market
Whether you’re a health or social care provider or looking for investment for a med-tech innovation.
Obtaining appropriate funding is not easy. Businesses have to ensure they are appropriately structured in order to be in a position to exploit funding opportunities. We can help to you to identify suitable financing options, such as venture capital, private equity, debt finance or SAFE investment and put business and contracting structures in place that will help you to access them.
Patient care and privacy are central to healthcare regulation.
Keeping abreast of the regulatory environment in which your business operates and complying with it is crucial to its viability.
Even businesses with effective corporate and clinical governance can experience issues, such as with the Care Quality Commission and MHRA. Our team supports health and social care providers with their dealings with the CQC and other compliance and regulatory matters. For those in the med-tech space, bringing new products to market can involve a huge regulatory burden. Whether you’re seeking CE marking or MHRA approval, we can help you to adopt legal structures to support your application.
Some healthcare businesses are just beginning their journey, others are evolving, and some are feeling the squeeze.
Ensuring that your business is structured appropriately to exploit your opportunities and value is more important than ever. Our team will support you on the full range of corporate and commercial dealings to help you to deliver long-term viability and succession; whether through corporate structuring, investment, commercialisation of products, contracting IP, licensing, HR support, data protection or real estate management.
All the latest views and insights
on current matters within Healthcare.
Corporate & Commercial
Corporate team advises on major healthcare acquisition
Avicenna was founded in 1992. Since then, its membership base has grown considerably to […]
Real Estate & Planning
‘Frustration’ continues as European Medicines Agency granted permission to appeal
At the initial hearing, the EMA failed to convince the High Court that a […]